NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 215 filers reported holding NOVAVAX INC in Q2 2023. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $180,037 | -2.0% | 24,867 | +0.6% | 0.00% | – |
| Q2 2023 | $183,647 | -68.3% | 24,717 | -70.4% | 0.00% | -100.0% |
| Q1 2023 | $579,438 | -32.6% | 83,613 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $859,542 | -44.3% | 83,613 | -1.4% | 0.00% | -50.0% |
| Q3 2022 | $1,544,000 | -64.6% | 84,813 | 0.0% | 0.00% | -63.6% |
| Q2 2022 | $4,362,000 | -36.1% | 84,813 | -8.5% | 0.01% | -15.4% |
| Q1 2022 | $6,829,000 | -48.9% | 92,716 | -0.7% | 0.01% | -45.8% |
| Q4 2021 | $13,364,000 | -30.7% | 93,411 | +0.4% | 0.02% | -36.8% |
| Q3 2021 | $19,289,000 | -5.0% | 93,042 | -2.7% | 0.04% | 0.0% |
| Q2 2021 | $20,303,000 | +378.1% | 95,628 | +308.2% | 0.04% | +375.0% |
| Q1 2021 | $4,247,000 | +49.3% | 23,426 | -8.2% | 0.01% | +33.3% |
| Q4 2020 | $2,845,000 | -7.7% | 25,516 | -10.3% | 0.01% | -14.3% |
| Q3 2020 | $3,083,000 | +45.7% | 28,456 | +12.1% | 0.01% | +40.0% |
| Q2 2020 | $2,116,000 | – | 25,386 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 4,758,833 | $396,649,000 | 7.73% |
| TSP Capital Management Group, LLC | 72,575 | $6,049,000 | 2.58% |
| Beirne Wealth Consulting Services, LLC | 22,250 | $1,855,000 | 1.51% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 93,000 | $7,752,000 | 1.41% |
| Rock Springs Capital Management LP | 570,598 | $47,559,000 | 1.30% |
| Sargent Investment Group, LLC | 38,059 | $3,033,000 | 1.14% |
| Harvest Investment Services, LLC | 19,580 | $1,631,000 | 0.97% |
| Parkman Healthcare Partners LLC | 40,000 | $3,334,000 | 0.94% |
| EAM Investors, LLC | 39,055 | $3,255,000 | 0.72% |
| EAM Global Investors LLC | 17,774 | $1,481,000 | 0.67% |